Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Emerging infectious diseases - 29(2023), 4 vom: 28. Apr., Seite 822-825

Sprache:

Englisch

Beteiligte Personen:

Bisoffi, Zeno [VerfasserIn]
De Santis, Nicoletta [VerfasserIn]
Piubelli, Chiara [VerfasserIn]
Deiana, Michela [VerfasserIn]
Perandin, Francesca [VerfasserIn]
Girardi, Pietro [VerfasserIn]
Heller, Luca [VerfasserIn]
Alba, Natalia [VerfasserIn]
Pomari, Carlo [VerfasserIn]
Guerriero, Massimo [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Cohort study
Coronavirus disease
Coronaviruses
Cumulative incidence
Elderly
Frail persons
Incidence
Italy
Journal Article
Pandemic
Prevalence
Reported data
Research Support, Non-U.S. Gov't
Respiratory infections
SARS-CoV-2
Sampling data
Serologic testing
Vaccine
Verona
Viruses
Zoonoses

Anmerkungen:

Date Completed 24.03.2023

Date Revised 02.04.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.3201/eid2904.221268

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM354239244